Sartorius officially opens bioreactor facility in Guxhagen

Invests €18m in manufacturing capacity expansion

The new building provides manufacturing space and offices for around 240 employees

Sartorius, the Goettingen, Germany-based laboratory and pharmaceutical supplier, formally opened its new plant in Guxhagen for the manufacture of bioreactors.

Approximately €18m has been invested in the 10,000m2 plant where Sartorius now manufactures bioreactors and further production equipment for the biopharmaceutical industry.

The new building complex, which took around 12 months to complete, provides manufacturing space and offices for around 240 employees.

Sartorius has moved from its former bioreactor production facility in Melsungen, Germany, where it had reached maximum capacity limits.

Joachim Kreuzberg

Joachim Kreuzburg, ceo and executive board chairman of Sartorius, said: ‘The new plant enables us to enhance our manufacturing processes substantially and creates additional capacity for us in view of the rising demand for biopharmaceutical production equipment. As a result, we are optimally prepared for further expansion, especially for single-use bioreactors.’